Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Carboplatin +/- Trastuzumab in Metastatic Breast Cancer
NCT00193076Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Nov 2003
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in breast cancer, sponsored by SCRI Development Innovations. Started Nov 2003; status: completed.
02
Drugs
gemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00193076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193076.